Brian Adams - Insider Trading Tracker

Introduction

This page provides a comprehensive analysis of the known insider trading history of Brian Adams. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

Companies with Reported Insider Positions

The SEC filings indicate Brian Adams has reported holdings or trades in the following companies:

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Brian Adams. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases KYMR / Kymera Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in KYMR / Kymera Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales KYMR / Kymera Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in KYMR / Kymera Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases RLAY / Relay Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in KYMR / Kymera Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2020-07-20	RLAY	Adams Brian	10,000	20.0000	10,000	20.0000	200,000	186	61.53	415,300	207.65

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales RLAY / Relay Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in KYMR / Kymera Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2025-07-29	RLAY	Adams Brian	18,276	3.6800	18,276	3.6800	67,256	10	3.2200	-8,406	-12.50
2025-07-28	RLAY	Adams Brian	1,637	3.7400	1,637	3.7400	6,122
2025-04-30	RLAY	Adams Brian	12,943	3.0000	12,943	3.0000	38,829
2025-04-28	RLAY	Adams Brian	1,644	3.1700	1,644	3.1700	5,211
2025-03-27	RLAY	Adams Brian	298	2.8400	298	2.8400	846
2025-01-30	RLAY	Adams Brian	20,791	4.4200	20,791	4.4200	91,896
2025-01-28	RLAY	Adams Brian	33,688	4.6300	33,688	4.6300	155,975
2024-12-27	RLAY	Adams Brian	299	4.3800	299	4.3800	1,310
2024-10-28	RLAY	Adams Brian	1,632	6.0600	1,632	6.0600	9,890
2024-09-27	RLAY	Adams Brian	295	7.5100	295	7.5100	2,215
2024-07-29	RLAY	Adams Brian	1,638	8.8500	1,638	8.8500	14,496
2024-06-27	RLAY	Adams Brian	295	6.2600	295	6.2600	1,847
2024-04-29	RLAY	Adams Brian	1,623	6.3800	1,623	6.3800	10,355
2024-03-27	RLAY	Adams Brian	348	7.7000	348	7.7000	2,680
2024-01-29	RLAY	Adams Brian	1,929	9.6400	1,929	9.6400	18,596
2023-12-27	RLAY	Adams Brian	294	11.5100	294	11.5100	3,384
2023-10-30	RLAY	Adams Brian	1,632	6.0300	1,632	6.0300	9,841
2023-09-27	RLAY	Adams Brian	294	8.3800	294	8.3800	2,464
2023-07-28	RLAY	Adams Brian	1,628	11.8000	1,628	11.8000	19,210
2023-06-27	RLAY	Adams Brian	294	12.1200	294	12.1200	3,563
2023-04-28	RLAY	Adams Brian	863	11.1600	863	11.1600	9,631
2023-04-28	RLAY	Adams Brian	1,936	11.1600	1,936	11.1600	21,606
2023-03-27	RLAY	Adams Brian	347	15.3600	347	15.3600	5,330
2023-01-30	RLAY	Adams Brian	864	21.5600	864	21.5600	18,628
2022-12-27	RLAY	Adams Brian	295	14.4900	295	14.4900	4,275
2022-10-28	RLAY	Adams Brian	728	21.5400	728	21.5400	15,681
2022-09-27	RLAY	Adams Brian	294	22.7300	294	22.7300	6,683
2022-07-28	RLAY	Adams Brian	734	21.2700	734	21.2700	15,612
2022-06-27	RLAY	Adams Brian	300	20.3100	300	20.3100	6,093
2022-04-28	RLAY	Adams Brian	708	25.5700	708	25.5700	18,104
2022-03-29	RLAY	Adams Brian	333	29.8700	333	29.8700	9,947
2021-12-27	RLAY	Adams Brian	295	33.1000	295	33.1000	9,764
2021-09-27	RLAY	Adams Brian	293	36.8700	293	36.8700	10,803
2021-06-28	RLAY	Adams Brian	293	35.8100	293	35.8100	10,492
2021-01-28	RLAY	Adams Brian	5,000	55.0500	5,000	55.0500	275,250

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Brian Adams as disclosed to the Securities Exchange Commission (SEC).